Trial Profile
Prevention of Human Cytomegalovirus (HCMV) Mother-to-Fetus Transmission by Administration of Virus-Specific Hyperimmune Globulin to Pregnant Women With Primary HCMV Infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2014
Price :
$35
*
At a glance
- Drugs Cytomegalovirus immune globulin (Primary)
- Indications Cytomegalovirus infections; Pregnancy
- Focus Therapeutic Use
- Acronyms CHIP
- 03 Apr 2014 Results published in the New England Journal of Medicine.
- 07 Dec 2011 Actual patient number is 124 according to ClinicalTrials.gov.
- 07 Dec 2011 Additional trial acronym (CHIP) identified as reported by ClinicalTrials.gov.